Skip to content
Screener

GeneDx Holdings WGS Total Current Liabilities

Total Current Liabilities at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$553.2M+43.7%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$90.13M+36.7%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$391.49M-6.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
$39.05M+30.6%
NeoGenomics logo
NeoGenomicsNEO
$105.88M+5.8%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.79B-11.7%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemMarch 31, 2026 (Unaudited)December 31, 2025
Accounts payable and accrued expenses$46,562$57,645
Short-term lease liabilities5,1294,404
Other current liabilities35,94846,859
Total current liabilities87,639108,908
Long-term debt, net of current portion96,73248,176
Long-term lease liabilities66,33156,046
Other liabilities711,641
Deferred taxes1,404757

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's total current liabilities?
GeneDx Holdings (WGS) reported total current liabilities of $87.64M in Q1 2026.
How has GeneDx Holdings's total current liabilities changed year-over-year?
GeneDx Holdings's total current liabilities increased by 26.0% year-over-year, from $69.54M to $87.64M.
What is the long-term trend for GeneDx Holdings's total current liabilities?
Over 5 years (2020 to 2025), GeneDx Holdings's total current liabilities has grown at a 8.2% compound annual growth rate (CAGR), from $73.44M to $108.91M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about GeneDx Holdings's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude